TY - JOUR ID - 132940 TI - Traditional herbal medicine in the treatment of patients infected with new Coronavirus JO - Health Biotechnology and Biopharma (HBB) JA - HBB LA - en SN - Y1 - 2021 PY - 2021 VL - 4 IS - 4 SP - 6 EP - 15 KW - COVID-19 KW - SARS KW - MERS KW - RNA genome DO - 10.22034/HBB.2021.02 N2 - The purposes of this review was in the direction of epidemiology, causative agents, symptoms, vaccine research probabilities and COVID-19 infection novel Corona viruses that was investigated in China. The COVID-19 has surrounded viruses along with a practical sensation one stranded RNA genome and a nucleocapsid of helical uniformity. The COVID-19 is an enormous family of viruses that are prevalent in a public and large number of species of animals including hens, camels, bats, cat, and cattle. Human corona viruses can cause gentle disorder identical to a common cough, cold, while others reason more acute disease MERS (Middle East Respiratory Syndrome) and SARS (Severe Acute Respiratory Syndrome). Thus spreading the COVID-19 should be closely investigated to recognize the growth of particularly virulent strains in society at an early stage and to simplify the evolution of enough preventive and therapeutic measurements. UR - https://www.healthbiotechpharm.org/article_132940.html L1 - https://www.healthbiotechpharm.org/article_132940_721c2b482fa66c91adc91d339c762313.pdf ER -